What is the first line treatment for a patient with migraine without aura that is not refractory?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Migraine Without Aura (Non-Refractory)

For mild to moderate migraine attacks, start with NSAIDs (ibuprofen 400-800 mg, naproxen 500-825 mg, or aspirin 1000 mg) as first-line therapy; for moderate to severe attacks or when NSAIDs fail, add a triptan to the NSAID regimen, as this combination is superior to either agent alone. 1

Treatment Algorithm Based on Attack Severity

Mild to Moderate Attacks

  • NSAIDs are the first-line choice for mild to moderate migraine attacks, with strong evidence supporting ibuprofen, naproxen sodium, aspirin, and diclofenac potassium 2, 1, 3
  • Specific dosing: ibuprofen 400-800 mg, naproxen 500-825 mg, or aspirin 1000 mg at attack onset 1
  • Alternative first-line option: combination of acetaminophen (1000 mg) plus aspirin plus caffeine, which provides synergistic analgesia 2, 4
  • Acetaminophen alone (1000 mg) has less efficacy and should only be used when NSAIDs are contraindicated 2

Moderate to Severe Attacks

  • Add a triptan to an NSAID for moderate to severe attacks that don't respond adequately to NSAIDs alone (strong recommendation) 2, 1
  • Triptans with the best evidence include oral sumatriptan, naratriptan, rizatriptan, and zolmitriptan 2, 3, 4
  • The triptan + NSAID combination represents the strongest recommendation from current guidelines and is superior to either agent alone 1

Critical Timing and Administration Principles

When to Take Medication

  • Treat early in the attack when headache is still mild to maximize efficacy 2, 5
  • Do not use triptans during the aura phase if aura is present 2
  • Early treatment improves outcomes across all medication classes 1, 5

Route Selection Based on Symptoms

  • For attacks with significant nausea or vomiting, select non-oral routes: subcutaneous sumatriptan or nasal spray formulations 2, 1
  • Add an antiemetic (metoclopramide 10 mg or prochlorperazine) even if vomiting is not present, as it provides synergistic analgesia 2, 1

Medication-Overuse Headache Prevention

The most critical pitfall to avoid is medication overuse headache, which occurs with frequent use of acute medications. 1, 6

  • Limit all acute migraine medications to no more than 2 days per week (or 10 days per month maximum) 1, 6, 5
  • Using acute medications more than twice weekly can paradoxically increase headache frequency and lead to daily headaches 1
  • If needing acute treatment more than twice weekly, initiate preventive therapy immediately 1

When Initial Treatment Fails

If NSAIDs Fail After 2-3 Attacks

  • Escalate to a triptan for subsequent attacks 1
  • Consider combination therapy (triptan + NSAID) from the start for future attacks 2, 1

If One Triptan Fails

  • Try a different triptan, as failure of one does not predict failure of others 2
  • Consider subcutaneous sumatriptan (6 mg) for patients who rapidly reach peak intensity or have vomiting 2, 1

For Relapse (Return of Symptoms Within 48 Hours)

  • Repeat triptan treatment or combine with fast-acting NSAIDs 2
  • This addresses the 40% of patients who experience symptom recurrence 1

Third-Line Options When All Triptans Fail

If all available triptans fail or are contraindicated, alternatives include:

  • Ditans (lasmiditan) 2
  • Gepants (ubrogepant, rimegepant) 2, 1
  • Dihydroergotamine (DHE) nasal spray or IV/IM formulations 1, 4

Contraindications and Special Populations

Triptan Contraindications

  • Ischemic heart disease or previous myocardial infarction 1
  • Uncontrolled hypertension 1
  • Other significant cardiovascular disease 1

NSAID Contraindications

  • Renal impairment (creatinine clearance <30 mL/min) 1
  • Active GI bleeding or history of GI bleeding 1
  • Aspirin/NSAID-induced asthma 1

When to Initiate Preventive Therapy

Preventive therapy should be considered when: 7, 1

  • Two or more migraine attacks per month with disability lasting 3 or more days per month 7
  • Using acute medications more than twice per week 7, 1
  • Contraindications to or failure of acute treatments 7
  • Quality of life continues to be impaired despite optimized acute therapy 1

References

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First-Line Treatment for Recurrent Headaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Migraine Treatment.

Continuum (Minneapolis, Minn.), 2015

Research

Medical Treatment Guidelines for Acute Migraine Attacks.

Acta neurologica Taiwanica, 2017

Guideline

Migraine Prevention Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.